EMJ GOLD: Pharma news, views and analysis

Join Helena and Isabel in ringing in the new year with a special episode in which five of our previous guests share their predictions for what could lie ahead for the pharmaceutical industry in 2023. Together, they discuss a broad range of topics including greater implementation of digital health, social media's impact on the space, new legislation and much more. If you are interested in learning more about the topic areas discussed in this episode, check out the following content: Looking forward to the future of pharma https://www.emg-gold.com/post/looking-forward-to-the-future-of-pharma-davidek-herron Utilising data lakes in pharma https://www.emg-gold.com/post/utilising-data-lakes-in-pharma Revealing the true value of medical affairs https://www.emg-gold.com/post/revealing-the-true-value-of-medical-affairs The changing rhythm of digital therapeutics https://www.emg-gold.com/post/the-changing-rhythm-of-digital-therapeutics Find a handy list of our guests' full episodes at https://www.emg-gold.com/post/podcast-the-2023-pharma-forecast

This GOLD Nugget episode sees Helena reflect on some of the best insights offered by Pav Rishiraj, Director and Head of Pharmacovigilance at Ipsen. She shares some of Pav's thoughts on how the often under-recognised field of pharmacovigilance has changed – particularly its rapid evolution during the COVID-19 pandemic – and its importance as a strategic enabler, as well as Pav's advice on what pharma should do to ensure teams feel valued and integral to the businesses they serve. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Pav's full episode: Pharmacovigilance past, present and future https://www.emg-gold.com/post/podcast-pharmacovigilance-past-present-and-future The physics of pharmacovigilance https://www.emg-gold.com/post/the-physics-of-pharmacovigilance

In the second of four special bonus episodes, Helena looks back at GOLD's conversation with Paul Simms, CEO, Impatient Health. She considers some of the gold nuggets that Paul shared, including insights on the current state of pharma's reputation and the ways in which pharma can recover and bolster its reputation. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Paul's full episode: Unpicking pharma's reputation in pop culture https://www.emg-gold.com/post/podcast-unpicking-pharma-s-reputation-in-pop-culture Reframing Pharma's bad boy reputation https://www.emg-gold.com/post/reframing-pharma-s-bad-boy-reputation Hear more from Paul: Is the pharma rep at death's door? https://www.emg-gold.com/post/is-the-pharma-rep-at-death-s-door The reality of the metaverse https://www.emg-gold.com/post/the-reality-of-the-metaverse

In the first of four special bonus episodes, Helena looks back at the launch episode of Season 3, which featured Dr Juby Jacob-Nara, Vice President and Global Medical Head for Respiratory, Allergy and Gastro-Intestinal Diseases, Sanofi. Helena considers some of the gold nuggets that Juby shared, including insights on the importance of cross-functional experience, team diversity and continual learning. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Juby's full episode: Meet GOLD's new catalyst – medical aficionado Juby Jacob-Nara https://www.emg-gold.com/post/podcast-meet-gold-s-new-catalyst-medical-aficionado-juby-jacob-nara Catalyst interview: Juby Jacob-Nara on medical affairs https://www.emg-gold.com/post/juby-jacob-nara-on-medical-affairs Revealing the true value of medical affairs https://www.emg-gold.com/post/revealing-the-true-value-of-medical-affairs Preparing MSLs for the spotlight https://www.emg-gold.com/post/preparing-msls-for-the-spotlight

This week's season finale episode welcomes back some friends of the podcast – most of whom we interviewed on the show this year – to reflect on the past 12 months and give us their take on their key highlights. Hear Aliya Omer, Claire Gillis, Robert Grimm, Michele Manto, Paul Simms and Wendy White, unravel the past year in pharma, looking at everything from access challenges to organisational change to huge wins for marketing approaches and sharing some fascinating insights. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: The impact of global instability https://www.emg-gold.com/_files/ugd/b8a9db_a8c25d06ae954bb98e0fa3448f259168.pdf Behind the headlines of the Inflation Reduction Act https://www.emg-gold.com/post/behind-the-headlines-of-the-inflation-reduction-act Revealing the true value of medical affairs https://www.emg-gold.com/post/revealing-the-true-value-of-medical-affairs Embracing pharma's digital transformation https://www.emg-gold.com/post/embracing-pharma-s-digital-transformation Elevating pharma's parental leave policies https://www.emg-gold.com/post/elevating-pharma-s-parental-leave-policies

This week on the podcast, GOLD discusses the field of pharma sales with James Harper, Founder and Managing Director, twentyeightb. James shares his story of joining the pharma industry, the incredible importance of striving to add value to every customer engagement, whether MSLs and sales reps could ever converge and the priority of mindset over toolset. All this stems from the inaugural event from James' new initiative 'Digital Pharma: Unlocked' – a group aiming to help the pharma industry see digital as a positive enablement tool. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Is the pharma rep at death's door? https://www.emg-gold.com/post/is-the-pharma-rep-at-death-s-door Revealing the true value of medical affairs https://www.emg-gold.com/post/revealing-the-true-value-of-medical-affairs A Field Force for the Future https://www.emg-gold.com/post/a-field-force-for-the-future Alexander Natz on pricing and access https://www.emg-gold.com/post/podcast-pharma-in-south-africa-access-pricing-and-reimbursement

In this week's episode, Helena and Isabel share an interview with GOLD's new catalyst John Wahba, Medical Head of the Global Digital Hub, GSK. In this teaser edition of the catalyst interview, John shares his motivations for joining the pharmaceutical industry, key takeaways from his time in the medical field, thoughts on digitally optimising MSL teams and much more. If you want to read the written interview in full, check out the link below. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: John Wahba on the medical affairs evolution Pharma in Japan Urgent need to boost trade for UK's life sciences, says ABPI

This week, the GOLD team presents a special episode to mark World AIDS Day, which is taking place on 1st December. Hear from Dr Nneka Nwokolo, Global Head of Patient Affairs, ViiV Healthcare, and Claire Gillis, CEO, VMLY&R Health, as they both discuss HIV stigma, prevention and care in the world today and how pharma can support healthcare professionals and patients. GOLD also speaks to former guest, Laurence Woollard, Director, On the Pulse Consultancy, and haemophilia patient advocate, to get his verdict on the new approval of a first-of-its-kind gene therapy for haemophilia B. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Access win for HIV patients in sub-Saharan Africa https://www.emg-gold.com/post/access-win-for-hiv-patients-in-sub-saharan-africa Monkeypox, misinformation and mitigating a pandemic https://www.emg-gold.com/post/monkeypox-misinformation-and-mitigating-a-pandemic Building campaigns with communities https://www.emg-gold.com/post/building-campaigns-with-communities Laurence Woollard on challenges facing the haemophilia community https://www.emg-gold.com/post/podcast-digital-solutions-cell-and-gene-therapy-and-haemophilia-in-focus

This week, GOLD chats to Silvia Taylor, Executive Vice President and Chief Communications Officer, Novavax. She reveals what it was like to join Novavax at the height of the pandemic, the importance of storytelling to ensure uptake and access to new vaccines and the advice she would give her younger self on how to succeed. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Pharma's sustainability agenda centre stage in new ABPI report https://www.emg-gold.com/post/pharma-s-sustainability-agenda-centre-stage-in-new-abpi-report 2022 Access to Medicine Index reveals improvement https://www.emg-gold.com/post/2022-access-to-medicine-index-reveals-improvement Keeping the spark alive in vaccine development https://www.emg-gold.com/post/keeping-the-spark-alive-in-vaccine-development How to enhance value and access across pharma https://www.emg-gold.com/post/podcast-how-to-enhance-value-and-access-across-pharma

This week, the GOLD team shares a conversation with Christoph Glaetzer, Chief Global Value and Access Officer, Johnson & Johnson. He discusses his lengthy career within value and access and his drive to enter the industry, his proudest achievements while working at J&J and the importance of having a good leader to learn from. And in news you might have missed, the team showcases some recent investment in the psychedelics market, a first-in-10-years paediatric vaccine and a new study investigating the prevalence of undiagnosed CKD. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Behind the headlines of the inflation reduction act https://www.emg-gold.com/post/behind-the-headlines-of-the-inflation-reduction-act Pharma in South Africa, access, pricing and reimbursement https://www.emg-gold.com/post/podcast-pharma-in-south-africa-access-pricing-and-reimbursement Margo Warren on global access to medicine https://www.emg-gold.com/post/podcast-margo-warren-on-global-access-to-medicine